[Gly22]-Amyloid beta 1-40 Arctic human, >=95% (HPLC)

Amino Acid Sequence

Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val

General description

β-Amyloid peptides are the major constituents of senile plaques and neurofibrillary tangles that occur in the hippocampus, neocortex, and amygdala of patients with Alzheimer′s disease. Aβ (1-40) whether soluble or insoluble differentiates AD vs high pathology controls. The Arctic mutation E22G causes early onset of Alzheimer′s compared to wild type and promotes protofibril formation and neurotoxicity.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Manufacturer Composition Storage Temp. Form Assay Price Quantity
3592282 [Gly22]-Amyloid beta 1-40 Arctic human, >=95% (HPLC) SIGMA-ALDRICH Peptide Content, ≥75% −20°C lyophilized ≥95% (HPLC)
£452.68 (exc VAT) per 1MG
-
+
3592283 [Gly22]-Amyloid beta 1-40 Arctic human, >=95% (HPLC) SIGMA-ALDRICH Peptide Content, ≥75% −20°C lyophilized ≥95% (HPLC)
£334.29 (exc VAT) per 500UG
-
+